glp 1 dexcom GLP-1 and G7 CGM: Better Diabetes Management Dexcom ONE Now Available in

5% NUTRITION DELIVERS the industry's most comprehensive formulations, made for elite level performance, with quality and purity guaranteed

To do so, you: Sterilize the vials with an alcohol swab to prevent pathogenic transmission Inject the needle syringe into the bacteriostatic water vial and draw out the amount indicated by your prescriber Inject the water-filled syringe into the tesamorelin vial and slowly introduce the water to the powder Remove the syringe Gently swirl to dissolve the powder into a solution (dont shake to mix, which can degrade the peptide and create foam) Reinsert the syringe into the tesamorelin vial and draw out the prescribed volume of solution Sterilize the injection site an area of subcutaneous fat in the belly, thigh, or arm Poke the syringe needle into the injection site and depress the plunger Dispose of the used syringe Tesamorelin often comes in a large vial meant to be used throughout the month, in which case reconstitution is necessary only once per shipment, not per dose

Seek medical advice if fatigue: Persists beyond several months without improvement, despite adequate nutrition and hydration Worsens progressively or becomes debilitating, significantly impairing daily activities or work capacity Is accompanied by severe or persistent gastrointestinal symptoms (intractable nausea, vomiting, diarrhoea, abdominal pain) Occurs alongside signs of dehydration (dark urine, dizziness, reduced urine output, dry mouth) Is associated with symptoms of hypoglycaemia (tremor, sweating, confusion, palpitations), particularly in patients taking concurrent insulin or sulphonylureas Urgent medical attention is required if patients experience: Severe abdominal pain , especially if radiating to the back, which may indicate pancreatitisa rare but serious adverse effect of GLP-1 medications

All seven authors are Novo Nordisk employees